Droxidopa [droxidopa]
topical
1
- Terms
-
3,4-dihydroxyfenylserin
DL-threo-3,4-dihydroxyfenylserin
droxidopa, (DL-Tyr)-izomer
erytro-3,4-dihydroxyfenylserin
threo-DOPS
-
3,4-Dihydroxyphenylserine
3,4-threo-DOPS
DL-threo-3,4-Dihydroxyphenylserine
Droxidopa, (DL-Tyr)-Isomer
erythro-3,4-Dihydroxyphenylserine
threo-DOPS
Persistent link
https://www.medvik.cz/link/D015103
Definition
A synthetic precursor of norepinephrine that is used in the treatment of PARKINSONIAN DISORDERS and ORTHOSTATIC HYPOTENSION.
- DUI
- D015103 MeSH Browser
- CUI
- M0023229
- CAS
- L-Tyrosine, beta,3-dihydroxy-, threo-
- Previous indexing
- Catechols (1971-1974); Serine (1971-1974)
- History note
- 1997 (1975); use 3,4-DIHYDROXYPHENYLSERINE 1975-1996
- Public note
- 1997; see 3,4-DIHYDROXYPHENYLSERINE 1975-96
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 1
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records